IMEIK Technology Development

QL Biopharma is engaged in the development of innovative and premium me-too drugs specifically aimed at treating chronic metabolic diseases. The company specializes in recombinant protein drugs that target conditions such as diabetes, obesity, and non-alcoholic fatty liver disease. By focusing on these therapeutic areas, QL Biopharma aims to enhance the quality of life for patients suffering from these prevalent health issues.

QL Biopharma is engaged in the development of innovative and premium me-too drugs specifically aimed at treating chronic metabolic diseases. The company specializes in recombinant protein drugs that target conditions such as diabetes, obesity, and non-alcoholic fatty liver disease. By focusing on these therapeutic areas, QL Biopharma aims to enhance the quality of life for patients suffering from these prevalent health issues.

Huons Global Co is a holding and pharmaceutical company dedicated to providing medical solutions for human health. Established in 1965, the company has a long history of manufacturing high-quality finished products, including Korea's first local anesthetics and plastic ampoule injections. Huons Global operates through three primary divisions: pharmaceuticals, medical devices, and cosmetics. The pharmaceutical division focuses on the production of ethical drugs, while the medical devices division develops equipment for the safe preparation of platelet-poor plasma and platelet concentrate from blood samples. Additionally, the company offers a range of cosmetic products, including cleansers, creams, and sunscreens. With a commitment to stringent quality control and ongoing research and development, Huons Global exports its pharmaceutical products to approximately 30 countries across North and South America, Europe, Japan, Asia, and Africa.